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Abstract
Posterior reversible encephalopathy syndrome (PRES) can present with focal neurologic deficits, mimicking a stroke
and can often represent a diagnostic challenge when presenting atypically. A high degree of suspicion is required
in the clinical setting in order to yield the diagnosis. Cerebral CT perfusion (CTP) is utilized in many institutions as
the first line in acute stroke imaging. CTP has proved to be a very sensitive measure of cerebral blood flow
dynamics, most commonly employed to delineate the infarcted tissue from penumbra (at-risk tissue) in ischemic
strokes. But abnormal CTP is also seen in stroke mimics such as seizures, hypoglycemia, tumors, migraines and
PRES. In this article we describe a case of PRES in an elderly bone marrow transplant recipient who presented with
focal neurological deficits concerning for a cerebrovascular accident. CTP played a pivotal role in the diagnosis and
initiation of appropriate management. We also briefly discuss the pathophysiology of PRES.
Background
Posterior reversible encephalopathy syndrome (PRES), as
the name suggests, is a constellation of symptoms
caused by reversible ischemia most commonly of the
posterior cerebral vasculature, thus affecting the parie-
tal-occipital region. Still other vascular territories can be
affected in PRES (see Table 1).Various terminologies
have been used to describe this condition, including
“reversible posterior leukoencephalopathy syndrome”
and “reversible posterior cerebral edema syndrome”
among others [1]. Hypertension (HTN) is the most
commonly identified cause of PRES, followed by medi-
cations, eclampsia and systemic factors. The pathophy-
siology of HTN related PRES is due to a failure of
cerebrovascular autoregulation, which in turn results in
vasogenic edema. Non-hypertensive PRES may be due
to an autoimmune or immune response to various sti-
muli [2]. The pathology usually affects the posterior
brain hemisphere (parietal-occipital region), which may
be a consequence of reduced sympathetic innervation in
this area. Usually it is a reversible phenomenon, as
indicated by the name, but if not recognized early and
treated appropriately, permanent brain injury may
ensue.
Case presentation
A 70-year-old white female presented to the emergency
room with symptoms of a cerebrovascular accident. She
had a history of multiple myeloma status post-autolo-
gous bone marrow transplant (BMT) with a condition-
ing regimen of high-dose melphalan 2 weeks prior to
presentation. She woke up the morning of presentation
and was found to be confused for a few minutes, fol-
lowed by a gradual improvement in mental status.
About an hour later, she started to experience a severe
headache associated with blurry vision, and shortly
thereafter she became disoriented again. Paramedics
identified agitation, right-side neglect, left gaze deviation
and right side weakness. On arrival in the emergency
department, the patient’s headache had resolved, but the
patient was still agitated and disoriented. The patient’s
altered mental status (AMS) required that the history be
obtained from the patient’s husband. There was no his-
tory of recent infection, fever, weight loss or trauma.
The review of systems was negative for photophobia,
seizures or any other neurological issues. Pertinent past
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provided the original work is properly cited.medical history was that of recent BMT with melphalan
and poorly controlled hypertension. She had had throm-
bocytopenia since the time of BMT and chemotherapy.
Her admission blood pressure was 221/114 with a mean
arterial pressure (MAP) of 145 mmHg. Her admission
NIH stroke scale score was 7, with problems in orienta-
tion, not following commands, not answering questions
appropriately, left gaze preference, reduced blink on sti-
mulus from the right and possible right-sided neglect.
Her visual acuity was reduced to finger movements and
light perception in both eyes. She was moving her extre-
mities equally, bilaterally. Reflexes were brisk through-
out with equivocal plantar response. The rest of the
neurological exam was limited, as the patient was not
following commands consistently. Our differential diag-
nosis at that time included cerebrovascular accident
(CVA), PRES (due to elevated BP, recent chemotherapy
and bone marrow transplant), seizures and complicated
migraine. Since there was no motor deficit associated
with the neglect and eye deviation, we were obligated to
consider a broad differential diagnosis, including PRES.
After the initial laboratory workup, we obtained a CT
head and a CT angiogram of the head and neck with
perfusion studies. The CTA of the head and neck failed
to identify any major vessel cutoff or any acute hypo/
hyper density, but the CTP demonstrated increased cer-
ebral blood volume (CBV), cerebral blood flow (CBF)
and reduced time to peak (TTP) in the posterior cere-
bral vascular distribution (see Figures 1 and 2). These
imaging features were consistent with PRES, and we
initiated intravenous anti-hypertensive medications. An
MRI brain was obtained, which showed abnormal
restriction in the parietal and occipital areas, confirming
the diagnosis of PRES (see Figure 3). Reduction of the
patient’s systolic BP from 220 to 180 was associated
with slight improvement in her visual acuity and orien-
tation within a couple of hours. Notable laboratory data
revealed a platelet count of 11,000/μl and hemoglobin of
11 g/dl. All other laboratory tests were within the nor-
mal limits. There was no evidence of thrombotic throm-
bocytopenic purpura (one of the causes of PRES), and
she was admitted with the diagnosis of PRES. At the
time of admission, PRES was considered to be secondary
Table 1 Common location of PRES
Common location of PRES
Parietal-occipital - most common.
Posterior frontal
Temporal
Thalamus
Cerebellum
Brainstem
Basal ganglia
Figure 1 CTP images in our case.
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motherapy and BMT. Over the subsequent 48 h, she
returned to baseline with improvement of her blood
pressure to normal range.
Discussion
PRES commonly presents with seizures (74%), altered
sensorium or encephalopathy, headache and visual
changes [3]. Other neurological features such as aphasia
and sensory changes are also seen. PRES can sometimes
present similarly to CVA, such as in our case. In such
cases, the patient may inadvertently and inappropriately
receive thrombolytic therapy. We again stress the point
that when a patient presents with stroke-like symptoms,
but with an inconsistent neurological exam, then the
stroke mimics such as PRES, seizures, migraine and
tumor should be included in the differential diagnosis.
The etiology of PRES can be broadly divided into five
main etiological groups. In order of clinical frequency,
PRES etiologies include HTN (61%), cytotoxic medica-
tions (19%), preeclampsia or eclampsia (6%) [3], autoim-
mune and systemic conditions, including sepsis (see
Table 2). Currently, the pathophysiology of PRES is con-
troversial. The most accepted theory of HTN-related
PRES is that of a hyperperfusion injury model (see
Figure 3). There will be a failure of cerebral autoregula-
tion in relation to the sudden elevation of blood pres-
sure. This sudden increase in MAP can lead to
arteriolar dilation, hyperperfusion, endothelial vascular
damage and disruption of the blood brain barrier. This
leads to vasogenic edema and potentially reversible
ischemia affecting both the grey and white matter [4].
Another less accepted theory argues that HTN-related
dysautoregulation results in vasoconstriction and hypo-
perfusion injury. However, the above hypothesis fails to
explain non-hypertensive PRES, and so some postulate
an autoimmune or immune response theory to various
stimuli [2].
We suggest that PRES is the result of various etiologi-
cal factors that lead to blood brain barrier injury either
by hyper- or hypoperfusion, endothelial dysfunction,
changes in blood vessel morphology, hypocapnia or
immune system activation [2,4,5]. It usually affects par-
ietal and occipital area, s but other regions can be
involved as well [6].
In our patient we feel that elevated MAP led to regio-
nal dysautoregulation, consequently causing hyperperfu-
sion, explaining the findings of increased CBF, CBV and
reduced TTP. It is important to recognize that this
patient had a recent history of bone marrow transplant
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Figure 2 MRI images in PRES.
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Figure 3 Most commonly attributed theory of PRES.
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causative factor in the development of PRES, or may
have independently contributed to the tissue injury.
We conclude that the mechanism of PRES is indivi-
dualized in each patient and depends mainly on the cau-
sative factor identified in each case. In the setting of
HTN, PRES is most likely due to the mechanism
described in the previously discussed theories. In the
setting of normotensive PRES, the mechanism may be
based on endothelial dysfunction, immune system acti-
vation and other systemic features. Although initially
edema is vasogenic in nature, a failure to reverse the
disease etiology will subsequently cause cytotoxic edema
and eventually brain infarction, further emphasizing the
importance of early disease recognition.
A high degree of suspicion is required to make this
diagnosis as the patient may present atypically. Since
many patients with PRES present with inadequate history
and AMS, brain imaging plays an important role in the
diagnosis of PRES. Even though MRI (particularly T2-
FLAIR) is the imaging of choice, CTP can play a signifi-
cant role that can reveal the cerebral hemodynamics
related with this condition. Since there is hyperperfusion
the CBF and CBV will be elevated, and TTP will be
reduced. The CTP can also have diametrically opposite
findings compared to our case [7] (see Table 3). The
brain MRI changes on FLAIR with no changes on diffu-
sion weighted images (DWI) suggest vasogenic edema.
Changes in both sequences (FLAIR and DWI) indicate
that the cytotoxic edema has set in, which may have an
unfavorable outcome. The authors imply that CTP is use-
ful but not superior to MRI in the diagnosis of PRES.
The management of this condition depends on the
etiology and should be initiated in a timely manner. The
treatment of the underlying cause is typically sufficient
to reverse this condition. However, a word of caution:
this condition can lead to irreversible brain insult if the
treatment is delayed or if there is prolonged brain insult,
in which case a brain insult then becomes irreversible
brain infarctions. Additionally, there may be hemorrha-
gic complications and raised intracranial pressure con-
tributing further to the cerebral damage [8]. The MAP
should be reduced quickly but with caution in the cases
of hypertensive PRES. In cases of non-hypertensive
PRES, especially in case of neoplastic drugs, the offend-
ing agent should be withdrawn quickly to avoid further
damage to the blood brain barrier. In the setting of
transplant, alternative medications can be substituted to
avoid organ rejections [9]. If an autoimmune etiology is
suspected, then immunosuppression has a role in the
management [10]. Seizures are managed with anti-epi-
leptic medications.
Conclusions
Posterior reversible encephalopathy syndrome is a rela-
tively rare syndrome that sometimes presents as a stroke
mimic. As such, it is important for the emergency physi-
cian to recognize. Urgent recognition and early initiation
of management of this condition are imperative as it
directly impacts the neurological outcome. Brain CT
perfusion can play an important role in the diagnosis.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any
Table 2 Etiology of PRES
Common causes of PRES
Hypertension
Eclampsia and preeclampsia
Drugs:
- Recreational: Cocaine, Amphetamines, PCP, LSD
- Others: Anti-depressants (Tricyclics, MAO Inhibitors), Bronchodilators, Erythropoietin, Midodrine, Fludrocortisone, Triple H therapy, Intravenous
immunoglobulins (IVIG).
Neoplastic drugs: Cyclosporine-A, Tacrolimus, Interferons, Indinavir, Cisplatin, Cytarabine, Gemcitabine.
Autoimmune and Systemic: Systemic lupus erythematosus (SLE), Scleroderma, Vasculitis like PAN, Wegener’s, Thrombotic thrombocytopenic purpura
(TTP), Henoch-Schönlein purpura, Hemolytic uremic syndrome (HUS), Amyloid angiopathy, Tumor lysis syndrome, Systemic inflammatory response
syndrome (SIRS), Sepsis, Multiple organ Dysfunction, Electrolyte imbalance (Hypomagnesemia, hypercalcemia), Hypocholesterolemia,, GBS, Head
injury, Renal failure due to any etiology.
Table 3 CT perfusion changes in various brain insults
Etiology CBF CBV MTT TTP
Infarct core ↓↓ ↑ ↑
Ischemic
penumbra
Varies; usually↓↑ Varies; usually
↑
↑
seizure ↑↑ ↓ ↓
PRES* Usually ↑ but can be
↓
↑ or
↓
Equivocal ↓
CBF = cerebral blood flow; CBV = cerebral blood volume; MTT = mean transit
time; TTP = time to peak.
*= CTP changes in PRES depend on whether it is a hyperperfusion or
hypoperfusion mechanism of PRES.
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available for review by the Editor-in-Chief of this
journal.
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